Effects of Soy Nut Supplementation on Glycemic Control and Llipid Profile in Diabetic Subjects

Effects of Soy nut Supplementation on Glycemic Control, Lipid Profile and Insulin Resistance in Type 2 Diabetic Subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014022616755N1

Enrollment

Registered

2015-11-14

Start date

2014-05-10

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Group I: Prescription 60 gram package of Soy nuts without salt, Daily in the morning and the evening for 8 weeks. Intervention 2: Group II: The second group as a control group does not

Group I: Prescription 60 gram package of Soy nuts without salt, Daily in the morning and the evening for 8 weeks.

Group II: The second group as a control group does not receive anything.

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Patients with type 2 diabetes; Patients with ages: 30-70 years old; BMI less than 35; FBS less than 250; HbA1c less than 8.5. Exclusion Criteria: Patients with liver failure; Renal failure; Heart failure; Using insulin; Allergy to soy nut.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose levels (FBS). Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;Hemoglobin A1c (HbA1c) levels. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;The serum levels of triglycerides, LDL, HDL, Total cholesterol. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;Fasting insulin levels. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;Insulin resistance. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: By Using the homeostasis model Assessment-insulin resistance (HOMA-ir) formula: fasting glucose (mmol/L) × fasting insulin (µU/ml)/22.5.	—

Measure

Time frame

Fasting blood glucose levels (FBS). Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;Hemoglobin A1c (HbA1c) levels. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;The serum levels of triglycerides, LDL, HDL, Total cholesterol. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;Fasting insulin levels. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: Venous sampling and sent to the laboratory.;Insulin resistance. Timepoint: Before intervention and after completion of intervention in the eighth week. Method of measurement: By Using the homeostasis model Assessment-insulin resistance (HOMA-ir) formula: fasting glucose (mmol/L) × fasting insulin (µU/ml)/22.5.

—

Secondary

Measure	Time frame
Body mass index (BMI). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Kg/m2 (Body weight to square of length ratio).;Systolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: mmHg, with manometer in sitting state from right arm.;Diastolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: mmHg, with manometer in sitting state from right arm.	—

Measure

Time frame

Body mass index (BMI). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Kg/m2 (Body weight to square of length ratio).;Systolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: mmHg, with manometer in sitting state from right arm.;Diastolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: mmHg, with manometer in sitting state from right arm.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Sedaghat

Ahvaz Jundishapur University of Medical Sciences

Alireza_sedaghat51@yahoo.com+98 61 3222 2922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026